CHADDS FORD, Pa., May 31, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer and Alan Levin, executive vice president and chief financial officer will present a corporate overview at the Jefferies Global Healthcare Conference on Tuesday, June 7, 2011 at 9:00 a.m. ET. The conference will be held at the Grand Hyatt in New York City, NY.
A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/. Click on Investor Relations, and then the link to the Event and Presentation. Participants should allow approximately ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.
Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care. We aim to be the premier partner to healthcare professionals and payment providers, delivering an innovative suite of complementary diagnostics, drugs, devices and clinical data to meet the needs of patients in areas such as pain, urology, oncology and endocrinology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit http://www.endo.com/.